ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 178 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,722,007 | -14.4% | 523,280 | -17.0% | 12.30% | -25.7% |
| Q2 2023 | $12,525,651 | +1.3% | 630,380 | -12.7% | 16.55% | +18.3% |
| Q1 2023 | $12,369,230 | -12.5% | 722,080 | 0.0% | 13.99% | +3.8% |
| Q4 2022 | $14,131,106 | +33.0% | 722,080 | +8.4% | 13.47% | +21.4% |
| Q3 2022 | $10,627,000 | +7.9% | 665,880 | -7.0% | 11.09% | +0.5% |
| Q2 2022 | $9,851,000 | -13.2% | 715,880 | 0.0% | 11.04% | +5.8% |
| Q1 2022 | $11,354,000 | +5.0% | 715,880 | +44.5% | 10.44% | +23.6% |
| Q4 2021 | $10,812,000 | – | 495,280 | – | 8.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 715,880 | $9,851,000 | 11.04% |
| RTW INVESTMENTS, LP | 15,802,802 | $217,447,000 | 5.62% |
| Amitell Capital Pte Ltd | 97,331 | $1,339,000 | 3.05% |
| Prosight Management, LP | 276,802 | $3,809,000 | 3.00% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $17,419,000 | 2.64% |
| Affinity Asset Advisors, LLC | 250,466 | $3,446,000 | 1.45% |
| COWEN AND COMPANY, LLC | 1,000,000 | $13,760,000 | 1.33% |
| Boxer Capital, LLC | 1,466,051 | $20,173,000 | 1.28% |
| Cormorant Asset Management, LP | 868,550 | $11,951,000 | 0.90% |
| MAVERICK CAPITAL LTD | 2,532,366 | $34,845,000 | 0.86% |